Existing colorectal cancer (CRC) blood tests fall short in detecting pre-cancerous advanced adenomas and offer only modest sensitivity for stage I CRC, significantly limiting life years gained from screening. At Radiate Biosciences, we are developing Radiate Nova—the first blood test designed to detect the vast majority of advanced adenomas and stage I CRC by employing novel technology. Our vision is to position Nova as a frontline screening tool, preceding  a colonoscopy, thereby offering a more accessible, less invasive solution to increase CRC screening adherence and maximize life years gained.